Inoue Yoko, Machida Osamu, Kita Yosuke, Yamamoto Toshiyuki
Division of Gene Medicine, Graduate School of Medical Science, Tokyo Women's Medical University, Tokyo, Japan.
Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan.
Intractable Rare Dis Res. 2022 Aug;11(3):120-124. doi: 10.5582/irdr.2022.01067.
The guidelines provided by American College of Medical Genetics and Genomics (ACMG) and the Association of Molecular Pathology (AMP) (ACMG/AMP guidelines) suggest a framework for the classification of clinical variants. However, the interpretations can be inconsistent, with each definition sometimes proving to be ambiguous. In particular, there can be difficulty with interpretation of variants related to the X-linked recessive trait. To confirm whether there are biases in the interpretation of inherited traits, we reanalyzed variants reported prior to the release of the ACMG/AMP guidelines. As expected, the interpretation ratio as pathogenic or likely pathogenic was significantly lower for variants related to the X-linked recessive trait. Evaluation of variants related to the X-linked recessive trait, hence, need to consider whether the variant is identified only in males in accordance with the X-linked recessive trait. The ACMG/AMP guidelines should be revised to eliminate the bias revealed in this study.
美国医学遗传学与基因组学学会(ACMG)和分子病理学协会(AMP)提供的指南(ACMG/AMP指南)提出了临床变异分类的框架。然而,这些解释可能不一致,每个定义有时都含糊不清。特别是,与X连锁隐性性状相关的变异解释可能存在困难。为了确认在遗传性状解释中是否存在偏差,我们重新分析了在ACMG/AMP指南发布之前报告的变异。正如预期的那样,与X连锁隐性性状相关的变异被解释为致病或可能致病的比例显著较低。因此,对与X连锁隐性性状相关的变异进行评估时,需要考虑该变异是否仅在符合X连锁隐性性状的男性中被鉴定出来。ACMG/AMP指南应进行修订,以消除本研究中揭示的偏差。